Company details

HEADCOUNT

25-99

ORG TYPE

Startup

SECTOR

Finance

WEBSITE

https://www.congenica.com

About the company

Congenica is a digital health company that builds software for analysing and interpreting genomic data for clinical use and research settings. Congenica also runs an Interpretation Services offer, where the clinical team supports analysis and reporting for suspected rare genetic disease cases. Public company profiles describe Congenica as founded in 2014 and based in the Cambridge area, with international customers. Congenica’s LinkedIn profile also states that Congenica became part of the SeqOne family as of September 2025.

Locations and presence

Congenica is headquartered in Cambridge, with a hub-based hybrid role currently advertised in Hinxton. Congenica also markets a “global footprint” through the customer base and platform deployment, but most hiring signals visible today point to the UK.

Palpable Score

59.3

/ 100

Congenica offers a credible early-career entry point through a Genome Analyst role that is explicitly framed as a stepping stone into NHS clinical scientist training. The score is held back by low visible volume of junior roles, plus mixed public interview feedback and limited public proof of early-career progression and retention.

Pillar 1: Early-career access

Score

12.3

/ 20

The company is actively hiring for a Genome Analyst role that is positioned as suitable experience before applying to the NHS Clinical Scientist Training Programme.
Congenica’s current open-roles footprint shown publicly is small, with the People and Vacancies page listing the Genome Analyst role as the only named opening.
The company invites speculative applications, which can help early-career candidates, but the lack of recurring 0–3 year roles limits reliable entry-level access.

Pillar 2: Hiring fairness and transparency

Score

12.0

/ 20

The company’s public interview reports include a structured sequence such as an HR call, a hiring manager call, and an in-person meeting discussing role scope and business ideas.
Congenica has public candidate feedback describing technical tests, including a multi-hour programming task and a test returned over a few days.
The company has at least one interview report where candidate expectations conflicted with the job spec, which is a fairness risk for early-career applicants relying on listings.

Pillar 3: Learning and support

Score

13.3

/ 20

The company places the Genome Analyst role inside a Clinical Team working alongside Clinical Scientists, which is a direct on-the-job learning setup.
Congenica describes the Genome Analyst role as experience-building for future NHS clinical scientist training, which signals a learning-oriented intent for early-career hires.
The company does not publicly set out a repeatable early-career development structure like formal mentoring, onboarding milestones, or progression checkpoints.

Pillar 4: Pay fairness and stability

Score

10.7

/ 20

The company’s Genome Analyst role is advertised as hybrid and includes listed benefits such as pension, private medical insurance, sick pay, and life insurance.
Congenica’s Genome Analyst posting is a fixed term contract, which is a stability trade-off for early-career candidates compared with a permanent role.
The company does not consistently publish salary ranges on the company careers pages, so pay fairness is hard to judge upfront without third-party estimates.

Pillar 5: Early-career outcomes

Score

11.0

/ 20

The company has a moderate Glassdoor profile, including a majority “recommend to a friend” figure and mid-3s scores across work-life balance, culture, and career opportunities.
Congenica has interview-experience metrics on Glassdoor showing a split of positive and negative experiences, which raises uncertainty about consistency for junior candidates.
The company does not publish early-career outcomes like promotions, retention over 12–24 months, or intern-to-hire conversion, so outcome scoring cannot go higher on evidence.